Immunomodulatory compounds from the sea: From the origins to a modern marine pharmacopoeia
Cutolo, E.A.; Campitiello, R.; Caferri, R.; Pagliuca, V.F.; Li, J.; Agathos, S.P.; Cutolo, M. (2024). Immunomodulatory compounds from the sea: From the origins to a modern marine pharmacopoeia. Mar. Drugs 22(7): 304. https://dx.doi.org/10.3390/md22070304
In: Marine Drugs. Molecular Diversity Preservation International (MDPI): Basel. ISSN 1660-3397; e-ISSN 1660-3397, more
|   |
| Keyword |
|
| Author keywords |
bioprospecting; inflammation; autoimmunity; synthetic biology; drug discovery; genetic engineering; immunomodulation; deep sea; systemic sclerosis; rheumatoid arthritis |
| Authors | | Top |
- Cutolo, E.A.
- Campitiello, R.
- Caferri, R.
- Pagliuca, V.F.
|
- Li, J.
- Agathos, S.P.
- Cutolo, M.
|
|
| Abstract |
From sea shores to the abysses of the deep ocean, marine ecosystems have provided humanity with valuable medicinal resources. The use of marine organisms is discussed in ancient pharmacopoeias of different times and geographic regions and is still deeply rooted in traditional medicine. Thanks to present-day, large-scale bioprospecting and rigorous screening for bioactive metabolites, the ocean is coming back as an untapped resource of natural compounds with therapeutic potential. This renewed interest in marine drugs is propelled by a burgeoning research field investigating the molecular mechanisms by which newly identified compounds intervene in the pathophysiology of human diseases. Of great clinical relevance are molecules endowed with anti-inflammatory and immunomodulatory properties with emerging applications in the management of chronic inflammatory disorders, autoimmune diseases, and cancer. Here, we review the historical development of marine pharmacology in the Eastern and Western worlds and describe the status of marine drug discovery. Finally, we discuss the importance of conducting sustainable exploitation of marine resources through biotechnology. |
|
